z-logo
Premium
HIV infection: oral lesions, CD4 + cell count and viral load in an ltalian study population
Author(s) -
Margiotta V.,
Campisi G.,
Mancuso S.,
Accurso V.,
Abbadessa V.
Publication year - 1999
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.1999.tb02019.x
Subject(s) - viral load , population , viral disease , human immunodeficiency virus (hiv) , medicine , immunology , virology , environmental health
The aims of this study were to assess types and prevalence of HIV‐related oral lesions and to correlate these lesions to the main laboratory parameters such as CD4 + cell count and plasma HIV‐RNA. The study population consisted of 104 consecutive HIV + patients living in Sicily (M=67, 64.4%; F=37, 35.6%; median age=35 years). CD4 + cell count and viral load were measured within 24 h of oral examinations. Data were managed and analysed by Epi‐Info 6.0. HIV‐related oral lesions, as classified by the EC‐Clearinghouse, were diagnosed in 35.6% of patients: these were of the Strongly Associated (SA) type in 22.1%, the Less Common Associated (LCA) type in 12.5%, and the Lesions Seen in HIV Infection (LS) type in 3.8%. CD4 + cell counts <200x10 6 /I were significantly associated only with SA lesions (P=0.03); median values of CD4 + cell count were also significantly correlated (P=0.02). Viral load, expressed both by median values of copies/ml (P=0.0001) and log 10 copies/ml (P=0.0003), was significanly associated only with SA lesions. Treatment failure was significantly correlated to SA lesions (P=0.04). Besides the confirmed correlation with CD4 depletion, the strong association with a high level of viral load could make SA oral lesions a useful tool for identifying progression of HIV infection and could be of value in monitoring antiretroviral therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here